S
Stella Mook
Researcher at Utrecht University
Publications - 40
Citations - 1511
Stella Mook is an academic researcher from Utrecht University. The author has contributed to research in topics: Esophageal cancer & Chemoradiotherapy. The author has an hindex of 14, co-authored 40 publications receiving 782 citations.
Papers
More filters
Journal ArticleDOI
Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial.
Pieter C. van der Sluis,Sylvia van der Horst,Anne M. May,Carlo Schippers,Lodewijk A.A. Brosens,Hans C. A. Joore,Christiaan C. Kroese,Nadia Haj Mohammad,Stella Mook,Frank P. Vleggaar,Inne H.M. Borel Rinkes,Jelle P. Ruurda,Richard van Hillegersberg +12 more
TL;DR: Robot-assisted minimally invasive thoracolaparoscopic esophageal cancer treatment with RAMIE resulted in a lower percentage of overall surgery-related and cardiopulmonary complications with lower postoperative pain, better short-term quality of life, and a better long-term postoperative functional recovery compared to OTE.
Journal ArticleDOI
Adaptive radiotherapy: The Elekta Unity MR-linac concept.
Dennis Winkel,Gijsbert H. Bol,Petra S. Kroon,Bram van Asselen,Sara S. Hackett,Anita M. Werensteijn-Honingh,Martijn Intven,Wietse S.C. Eppinga,Rob H N Tijssen,Linda G W Kerkmeijer,Hans C.J. de Boer,Stella Mook,Gert J. Meijer,J. Hes,Mirjam Willemsen-Bosman,Eline N. de Groot-van Breugel,Ina M. Jürgenliemk-Schulz,Bas W. Raaymakers +17 more
TL;DR: The Elekta Unity MR-linac adaptive radiotherapy concept is explained and different methods for dose re-calculation and optimization are discussed, with full online re-planning being the most robust adaptive planning method for the Unity.
Journal ArticleDOI
Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: A single-arm phase ii feasibility trial (PERFECT)
Tom van den Ende,Nicolien C. de Clercq,Mark I. van Berge Henegouwen,Suzanne S. Gisbertz,Elisabeth D. Geijsen,Rob H.A. Verhoeven,Sybren L. Meijer,Sandor Schokker,Mark P. G. Dings,Jacques J. Bergman,Nadia Haj Mohammad,Jelle P. Ruurda,Richard van Hillegersberg,Stella Mook,Max Nieuwdorp,Tanja D. de Gruijl,Tanya T.D. Soeratram,Bauke Ylstra,Nicole C.T. van Grieken,Maarten F. Bijlsma,Maarten C.C.M. Hulshof,H.W.M. van Laarhoven +21 more
TL;DR: In this paper, the authors investigated the feasibility and efficacy of nCRT combined with programmed-death ligand-1 (PD-L1) inhibition for esophageal adenocarcinoma (rEAC).
Journal ArticleDOI
R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology.
Helena M. Verkooijen,Linda G W Kerkmeijer,Clifton D. Fuller,R. Huddart,Corinne Faivre-Finn,Marcel Verheij,Stella Mook,Arjun Sahgal,Emma Hall,Christopher J. Schultz +9 more
TL;DR: Key distinctive features of R-IDEAL include the important role of predicate and modeling studies, randomization at an early stage in the development of the technology, and long-term follow-up for late toxicity.
Journal ArticleDOI
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy
Sophie R de Mol van Otterloo,John P. Christodouleas,Erwin L. A. Blezer,Hafid Akhiat,K.J. Brown,Ananya Choudhury,Dave Eggert,Beth Erickson,Corinne Faivre-Finn,Clifton D. Fuller,Joel W. Goldwein,Shaista Hafeez,Emma Hall,Kevin J. Harrington,Uulke A. van der Heide,Robert Huddart,Martijn Intven,Anna M. Kirby,Susan Lalondrelle,Claire McCann,Bruce D. Minsky,Stella Mook,Marlies E. Nowee,Uwe Oelfke,Kristina Orrling,Arjun Sahgal,Jeffrey G Sarmiento,Christopher J. Schultz,Robbert J.H.A. Tersteeg,Rob H N Tijssen,Alison Tree,Baukelien van Triest,William A. Hall,Helena M. Verkooijen +33 more
TL;DR: The multi-institutional MOMENTUM study has been set up to collect clinical and technical patient data to advance technical development, and facilitate evidenced-based implementation of MR-linac technology with the ultimate purpose to improve tumor control, survival, and quality of life of patients with cancer.